Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Net Benefit From tPA for Stroke Patients Receiving Prior Antiplatelet Therapy
Link ID 4163
Title Net Benefit From tPA for Stroke Patients Receiving Prior Antiplatelet Therapy
Url http://www.medscape.com/viewarticle/571728?src=rss
Description Despite a higher incidence of intracranial hemorrhage, patients using antiplatelet therapy before a stroke appear to benefit more from tissue plasminogen activator vs those not using prior therapy. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Mar 21, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. A Case of Pulmonary Arterial Hypertension: The Challenge of Improving Outcomes
  Symptoms of PAH are addressed in this case study to improve diagnosis, treatment, and patient outcomes. Medscape Pulmonary Medicine
Category:   Articles > Cardiology


2. Celecoxib No Clinical Utility as Chemopreventive Agent, Experts Say
  They also warn that new trials studying the well-known pain reliever in high doses would be unethical. Medscape Medical News
Category:   Articles > Cardiology


3. FDA Renews Caution Against Mixing Simvastatin >20 mg/day and Amiodarone
  Patients who take more than 20 mg/day of simvastatin in addition to amiodarone are at increased risk for rhabdomyolysis, the Food and Drug Administration has reminded physicians in the US. Medscape Medical News
Category:   Articles > Cardiology


4. Vernakalant Bests Placebo for Converting AF Patients to Sinus Rhythm After Cardiothoracic Surgery
  Results of the ACT II study suggest that the investigational antiarrhythmic may help almost half of all patients who develop atrial fibrillation or flutter after CABG or valve surgery. Heartwire
Category:   Articles > Cardiology


5. HYVET: BP Lowering Reduces Fatal Stroke, All-Cause Mortality in the Elderly
  Randomized trial results show that antihypertensive treatment with indapamide, with or without the addition of perindopril, reduced fatal stroke, all-cause mortality, and heart failure in patients 80 years of age and older, although the primary end point, fatal or nonfatal stroke, did not reach statistical significance. The trial was halted early because of the reduction in all-cause mortality. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS